Study With Tocilizumab in Combination With Venetoclax and Azacitidine Chemotherapy in Patients With Acute Myeloid Leukemia
NCT07392814
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Leukemia Acute Myeloid - AML
Interventions
DRUG:
increase dose of tocilizumab
Sponsor
Nantes University Hospital